HIV and Hepatitis.com Coverage of the
14th Annual Conference on Retroviruses
and Opportunistic Infections (14th CROI)

February 25 - 28, 2007, Los Angeles, CA
CD4+ T Cell Recovery and Reconstitution of Gut Tissue In AIDS Patients Treated with Viramune plus Trizivir

Gut-associated lymphoid tissue (GALT) harbors the majority of CD4+ T cells and is rapidly depleted in early HIV infection. Prior study results suggest that reconstitution of CD4+ T cells in HAART-treated individuals is less complete in GALT than in peripheral blood (PB).

Most studies have evaluated GALT by flow cytometry, which provides relative estimates of CD4+ T cells. In the present study, researchers hypothesized that reconstitution of CD4+ T cells in GALT may have been underestimated by this method and that absolute numbers of CD4+ T cells reconstituted in GALT exceed those in PB.

8 untreated AIDS patients enrolled in a clinical trial underwent colonic biopsies and provided PB samples at baseline, 24 and 48 weeks after starting nevirapine (Viramune) plus abacavir/zidovudine/lamivudine (Trizivir.)

Based on their assessment of the biopsies and other data, the researchers conclude, "Treatment with Viramune/Trizivir in advanced HIV-1 infection results in substantial recovery of CD4+ T cells and reconstitution of tissue architecture in GALT. Increases in CD4+ T cells are significantly larger in GALT than PB, particularly during the first 24 weeks of therapy."

Link to full study abstract.

University of Colorado at Denver and Health Sciences Center, Denver, CO, Weber State University, Ogden, UT, Denver Department of Public Health, Therapeutic Concepts, PA, Houston, TX, Pharmaceutical Product Development, Inc., Menlo Park, CA, AnorMED, Inc, Langley, BC.

03/09/07

Reference
E Connick, D Shenefelt, J Folkvord, and others. SubstantialCD4+ T Cell Recovery and Reconstitution of Tissue Architecture in Gut Associated Lymphoid Tissue (GALT) in Advanced HIV-1 Infection Following Initiation of HAART. 14th Conference on Retroviruses and Opportunistic Infections. Los Angeles. February 25-28, 2007. Abstract 28 (oral).












































14th croi